Syndax Pharmaceuticals Inc Cash Flow-to-Debt Ratio
Syndax Pharmaceuticals Inc cash flow-to-debt ratio. Syndax Pharmaceuticals Inc (SNDX) has a Cash Flow-to-Debt Ratio of -0.04x as of June 2026, meaning its operating cash flow of $-30.27 Million could theoretically repay 0% of its total liabilities ($688.55 Million) in one year. Check how high is Syndax Pharmaceuticals Inc's earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Syndax Pharmaceuticals Inc (2011–2025)
Cash flow-to-debt ratio of Syndax Pharmaceuticals Inc from 2011 to 2025. Historical debt coverage capacity for Syndax Pharmaceuticals Inc across 15 annual periods. Check cash flow reinvestment rate of Syndax Pharmaceuticals Inc to assess the company's total reinvestment commitment from operating cash flow.
Syndax Pharmaceuticals Inc Cash Flow-to-Debt Ratio by Year (2011–2025)
Syndax Pharmaceuticals Inc cash flow-to-debt ratio by year from 2011 to 2025. Year-by-year debt coverage analysis for Syndax Pharmaceuticals Inc. For the full cash flow conversion analysis, see cash flow conversion of Syndax Pharmaceuticals Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.69x | $-322.98 Million | $465.08 Million | ▼ -10.3% |
| 2024 | -0.63x | $-274.90 Million | $436.69 Million | ▲ +77.0% |
| 2023 | -2.74x | $-160.60 Million | $58.68 Million | ▲ +39.0% |
| 2022 | -4.49x | $-133.68 Million | $29.79 Million | ▼ -736.1% |
| 2021 | 0.71x | $29.13 Million | $41.29 Million | ▲ +147.9% |
| 2020 | -1.47x | $-71.26 Million | $48.42 Million | ▲ +7.2% |
| 2019 | -1.59x | $-50.61 Million | $31.93 Million | ▲ +28.5% |
| 2018 | -2.22x | $-68.53 Million | $30.89 Million | ▼ -53.9% |
| 2017 | -1.44x | $-47.37 Million | $32.87 Million | ▼ -2.0% |
| 2016 | -1.41x | $-35.16 Million | $24.87 Million | ▼ -1250.8% |
| 2015 | -0.10x | $-2.43 Million | $23.20 Million | ▲ +86.5% |
| 2014 | -0.78x | $-14.39 Million | $18.53 Million | ▲ +44.5% |
| 2013 | -1.40x | $-7.29 Million | $5.21 Million | ▼ -364.3% |
| 2012 | -0.30x | $-9.28 Million | $30.80 Million | ▲ +28.3% |
| 2011 | -0.42x | $-10.02 Million | $23.84 Million | — |